Aurelie Vuilleumier
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma.
Journal: JCI insight
Published: December 09, 2024
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.
Journal: Swiss medical weekly
Published: April 03, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
Journal: Familial cancer
Published: October 22, 2021
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Journal: Scientific reports
Published: November 03, 2020
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients.
Journal: Frontiers in oncology
Published: April 26, 2019
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Journal: Scientific reports
Published: February 22, 2019
Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
Journal: Annales de dermatologie et de venereologie
Published: November 21, 2018
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
Journal: Breast cancer research and treatment
Published: August 15, 2018
Screening of ovarian cancer : not for tomorrow
Journal: Revue medicale suisse
Published: June 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026